EUCTR2004-000827-13-IT进行中（未招募）不适用
inezolid In The Treatment Of Subjects With Nosocomial Pneumonia Proven To Be Due To Methicillin-Resistant Staphylococcus Aureus
适应症
试验速览
- 阶段
- 不适用
- 状态
- 进行中（未招募）
- 发起方
- PFIZER
- 入组人数
- 1,200
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional clinical trial of medicinal product
入排标准
- 性别
- All
入选标准
- •Are the trial subjects under 18? no
- •Number of subjects for this age range:
- •F.1.2 Adults (18-64 years) yes
- •F.1.2.1 Number of subjects for this age range
- •F.1.3 Elderly (>=65 years) yes
- •F.1.3.1 Number of subjects for this age range
排除标准
- 未提供
研究者
相似试验
进行中（未招募）
不适用
inezolid In The Treatment Of Subjects With Nosocomial Pneumonia Proven To Be Due To Methicillin-Resistant Staphylococcus Aureus - N/AEUCTR2004-000827-13-BEPfizer Global Pharmaceutical Group1,200
进行中（未招募）
1 期
inezolid In The Treatment Of Subjects With Nosocomial Pneumonia Proven To Be Due To Methicillin-Resistant Staphylococcus Aureus - N/AEUCTR2004-000827-13-ESPfizer, S.A.1,200
进行中（未招募）
不适用
inezolid In The Treatment Of Subjects With Nosocomial Pneumonia Proven To Be Due To Methicillin-Resistant Staphylococcus Aureus - N/AMRSA Infection - Nosocomial PneumoniaMedDRA version: 7.0Level: LLTClassification code 10052596EUCTR2004-000827-13-DEPfizer Inc.1,200
已完成
不适用
inezolid for the Treatment of Suspected or Proven Gram-positive Infections: A Randomized, Open-label Trial Comparing Linezolid IV/PO and Teicoplanin IV or IM.-J18-L03-I38 Endocarditis, valve unspecifiedEndocarditis, valve unspecifiedI38J18L03PER-009-00PHARMACIA & UPJOHN INTERAMERICAN CORPORATION,
尚未招募
不适用
Should a patient with a clinically suspected scaphoid fracture be treated with a cast?clinical suspected scaphoid fracture. Klinische verdenking scaphoid fractuurNL-OMON20183Erasmus MC180